2024 Annual Meeting | Industry Therapeutic Update from Alexion: Establishing Zero Relapses as the New Standard: A New Treatment Redefining NMOSD Treatment Success
Industry Therapeutic Update from Alexion: Establishing Zero Relapses as the New Standard: A New Treatment Redefining NMOSD Treatment Success
Faculty Disclosures
Benjamin J. Osborne, MD, FAAN
Dr. Osborne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.